Private credit finds its liquidity valve in CLOs

KKR reopened its Lending Partners shelf with a $624 million static CLO. Bridgepoint reset its debut European CLO at €307.85 million. The reinvestment period now runs to 2031. Janus Henderson's AAA CLO ETF crossed $30 billion in assets. Those moves, taken together, point to a liquidity valve being built outside the banking system.

These announcements landed together. Managers are converting seasoned direct-lending portfolios into rated term funding, while retail investors buy the safest slice of the CLO stack. The retail bid is what makes the arbitrage work.

A static CLO does not reinvest. The manager puts an existing pool of loans into a vehicle, sells rated notes against it, and lets the collateral amortize. KKR's $624 million shelf reopening turns a seasoned Lending Partners portfolio into non-recourse term funding at a fixed cost, as PWD's records show. It is a way to raise liquidity without selling the loans.

Bridgepoint's reset is the same idea by another route. A reset reworks an existing CLO's liabilities, often at lower spreads, while keeping the collateral in place. Bridgepoint reset its debut European CLO at €307.85 million, ACI reported. The reinvestment horizon now stretches to 2031. That buys time and lowers the vehicle's cost of capital.

CIC Private Debt did much the same with Victory Street CLO I, resetting it at €307.5 million. Nearly 90% of investors stayed in. That holding power suggests tier-one pricing kept the deal together. PWD's tracking shows a third CLO is next.

Janus Henderson's AAA CLO ETF, ticker JAAA, has crossed $30 billion in assets. It took in $5.7 billion this year. That intake makes it the second-largest active fixed income ETF, according to PWD's tracking. The ranking is by 2026 inflows. The fund buys triple-A CLO paper, the same notes managers issue in resets and static deals.

The fund's daily liquidity is the key. CLO AAA notes have always had institutional buyers. But an ETF that can grow by billions in weeks creates a marginal bid that did not exist a decade ago. CIFC and Palmer Square have each priced their third CLO this year. The notes came at 121 basis points. That spread reflects this demand. Repeat issuers are locking in terms that would have looked tight only a few years ago.

That spread matters for the reset math. If a manager can issue AAA notes at 121 basis points and sell them into an ETF, the cost of term funding falls. The private credit managers doing resets are funding themselves through a retail wrapper instead of a bank.

The direct-lending calendar is quiet. Origination volume has sagged, and managers need another source of liabilities. Serone has hired three people, according to PWD's tracking. The firm is aiming for a debut US CLO by year-end. Mountain Point priced its second CLO. The deal came six months after its debut, with Bank of America still as arranger. New issuers are entering even as the underlying loan market cools.

European managers are repricing seasoned collateral too. KKR and Sculptor brought Avoca XXI and Sculptor CLO VI back through Citi and JPMorgan, PWD's records show. That is not new origination. It is existing loans being financed more cheaply.

The result is a funding market that turns loan portfolios into term liabilities without a bank on the other side. Managers originate loans, warehouse them, then issue CLOs when the arbitrage makes sense. The retail bid determines whether that flow continues.

Static CLOs have their limits. Because the collateral cannot be reinvested, a manager gives up flexibility in exchange for term funding. If a loan pays down early, the proceeds go to noteholders rather than into new deals. But for a portfolio sitting in a shelf with no immediate exit, that trade-off is acceptable.

The question now is whether the retail bid holds. JAAA has taken in $5.7 billion this year. That puts it second among active fixed income ETFs, according to PWD's tracking. If that slows, new-issue spreads may widen and the reset arbitrage gets harder. For now, managers have a buyer.

Watch Serone's debut US CLO and whether CIC returns with a third. Both are tests of whether the retail bid can hold as origination slows.